等待开盘 10-03 09:30:00 美东时间
-0.010
-0.86%
Short interest data from late September 2026 highlights deeply divided investor sentiment across small-cap healthcare stocks (market capitalizations up to $2B). Heavy bearish bets remain concentrated ...
10-02 22:15
Surrozen (SRZN) on Friday announced plans to advance its bifunctional antibody SZN-8141 into clinical development for diabetic macular edema following the FDA clearance of its Investigational New Drug...
10-02 20:45
BICO Group AB Class B ( ($SE:BICO) ) has issued an announcement. BICO Group AB ...
10-02 13:32
Nanobiotix (NBTX) said on Thursday that it appointed Arnd Christ as chief financial officer and member of the company’s executive board, effective October 1, 2026. Christ succeeds Bart Van Rhijn, who ...
10-02 04:37
Oxford BioDynamics ( ($GB:OBD) ) has provided an announcement. Oxford BioDynami...
10-01 23:12
Vir Biotechnology (VIR) has appointed Aziz Sawaf as executive vice president and chief financial officer, effective October 5, 2026, to lead the finance, IT, and investor relations functions. Sawaf b...
10-01 20:38
Foghorn Therapeutics (FHTX) lost nearly 50% in premarket trading on Thursday as the Watertown, MA-based biotech announced massive layoffs after Eli Lilly (LLY) ended its 2021 collaboration with the co...
10-01 20:02
Defense Secretary Pete Hegseth on Wednesday ordered the launch of Project Meridian, an initiative aimed at identifying emerging technologies and weapons that could shape future U.S. military capabilit...
10-01 05:38
Liquidia Corp. (LQDA) quickly dropped 25% after a court ruling in its ongoing patent dispute with United Therapeutics (UTHR) over its Yutrepia drug. United Therapeutics rose 6.2%. The court said Liqui...
09-30 23:42
Immix Biopharma completed a $117.1 million stock offering to fund NXC-201 development and general corporate purposes. The offering was led by J.P. Morgan and included leading U.S. biotechnology institutional investors and mutual funds. NXC-201, a CAR-T cell therapy for relapsed/refractory AL Amyloidosis, has received Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy designation from the FDA.
09-30 21:15